Try our Advanced Search for more refined results
November 20, 2017
Rose v. Array Biopharma Inc. et al
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 29, 2021
Array Biopharma, Investors Agree To $8.5M Settlement Deal
Array Biopharma Inc. has agreed to pay $8.5 million to settle claims it failed to properly detail its efforts to secure U.S. Food and Drug Administration approval for a new skin cancer treatment, the company's investors told a federal judge in Colorado.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login